グリコーゲン蓄積症(GSD):世界の治験レビュー(2015年上半期版)

GlobalDataが発行した調査報告書(GDHC2552CTIDB)
◆英語タイトル:Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2552CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年1月31日
◆ページ数:58
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界におけるグリコーゲン蓄積症(GSD) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - グリコーゲン蓄積症(GSD)
  - 当レポートの概要
・グリコーゲン蓄積症(GSD):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015″ provides data on the Glycogen Storage Disorders (GSD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glycogen Storage Disorders (GSD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glycogen Storage Disorders (GSD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Glycogen Storage Disorders (GSD) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Sanofi 27
Clinical Trial Overview of Sanofi 27
Promethera Biosciences S.A. 29
Clinical Trial Overview of Promethera Biosciences S.A. 29
Clinical Trial Overview of Top Institutes / Government 30
Dipartimento di Pediatria Salus Pueri 30
Clinical Trial Overview of Dipartimento di Pediatria Salus Pueri 30
Institut de Myologie 31
Clinical Trial Overview of Institut de Myologie 31
Aarhus University Hospital 32
Clinical Trial Overview of Aarhus University Hospital 32
Baylor Research Institute 33
Clinical Trial Overview of Baylor Research Institute 33
University College London 34
Clinical Trial Overview of University College London 34
University Hospital Hamburg-Eppendorf 35
Clinical Trial Overview of University Hospital Hamburg-Eppendorf 35
University of Copenhagen 36
Clinical Trial Overview of University of Copenhagen 36
University of Pittsburgh 37
Clinical Trial Overview of University of Pittsburgh 37
Five Key Clinical Profiles 38
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Region, 2015* 6
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
Glycogen Storage Disorders (GSD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Glycogen Storage Disorders (GSD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 27
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Promethera Biosciences S.A., 2015* 29
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dipartimento di Pediatria Salus Pueri, 2015* 30
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Myologie, 2015* 31
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2015* 32
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor Research Institute, 2015* 33
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2015* 34
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Hamburg-Eppendorf, 2015* 35
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2015* 36
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 37

List of Figures
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
Glycogen Storage Disorders (GSD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Glycogen Storage Disorders (GSD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 57

【レポートのキーワード】

グリコーゲン蓄積症(GSD)、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ グリコーゲン蓄積症(GSD):世界の治験レビュー(2015年上半期版)(Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆